P-007: HYDROXYUREA FOR THE MANAGEMENT OF SICKLE CELL DISEASE IN LOW- AND MIDDLE-INCOME COUNTRIES: A SYSTEMATIC REVIEW (2000–2022)

por L., TSHILOLO, K., MARFO, F., ADISON, S., KHAN, V., PAINTSIL
Publicado 2022

O-01: HYDROXYUREA REDUCES THE TRANSFUSION BURDEN IN CHILDREN WITH SICKLE CELL ANEMIA IN SUB-SAHARAN AFRICA: THE REACH EXPERIENCE

por A., POWER-HAYS, G., TOMLINSON, L., TSHILOLO, B., SANTOS, T., WILLIAMS, P., OLUPOT-OLUPOT, L., SMART, P., MCGANN, S., STUBER, T., LATHAM, R., WARE
Publicado 2022

PI-07: THE INTERNATIONAL HEMOGLOBINOPATHY RESEARCH NETWORK (INHERENT): AN INTERNATIONAL INITIATVE TO STUDY THE ROLE OF GENETIC MODIFIERS IN HEMOGLOBINOPATHIES

por P., KOUNTOURIS, C., STEPHANOU, N., ARCHER, F., BONIFAZI, V., GIANNUZZI, K., KUO, A., MAGGIO, J., MAKANI, M., MAÑÚ PEREIRA, K., MICHAILIDOU, S., NKYA, O., NNODU, S., TROMPETER, L., TSHILOLO, A., WONKAM, B., ZILFALIL, B., INUSA, M., KLEANTHOUS
Publicado 2022